TRUPCR® C-KIT Mutation Detection Kit | TRUPCR Europe
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasms: Molecular Therapy
Mutation D816V Alters the Internal Structure and Dynamics of c-KIT Receptor Cytoplasmic Region: Implications for Dimerization and Activation Mechanisms | PLOS Computational Biology
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis - eBioMedicine
Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype - ScienceDirect
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis | Leukemia
Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis | bioRxiv
Bidirectional sequencing of KIT exon 17 demonstrated a D816V mutation... | Download Scientific Diagram
Gene Expression Profiling of Human c-Kit Mutant D816V
Hotspot Mutations in KIT Receptor Differentially Modulate Its Allosterically Coupled Conformational Dynamics: Impact on Activation and Drug Sensitivity | PLOS Computational Biology
KIT D816V ddPCR | ARUP Laboratory
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications | Modern Pathology
Novel approaches to treating advanced systemic mastocytosis | CPAA
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis - eBioMedicine
Finding the right KIT inhibitor for advanced systemic mastocytosis | Nature Medicine
IJMS | Free Full-Text | KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile
KIT D816V and the cytokine storm in mastocytosis: production and role of interleukin-6 | Haematologica
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression
c-Kit (D816V) Protein, active, 10 µg | 14-611
IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
Gene Expression Profiling of Human c-Kit Mutant D816V
KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes - Navarro‐Navarro - 2023 - Allergy - Wiley Online Library
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis - ScienceDirect
The D816V mutation in the catalytic domain of the c-Kit receptor... | Download Scientific Diagram
Frontiers | Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
Dasatinib overrides the differentiation blockage in a patient with mutant- KIT D816V positive CBFβ-MYH11 leukemia | Oncotarget
